top of page

Biden Administration Policy Jeopardizes The System That Gave Us Gene Editing

The FDA just approved the first drug based on CRISPR, the revolutionary gene-editing technology. The medication treats sickle cell disease -- a condition that overwhelmingly affects Black Americans -- by altering the DNA of bone marrow stem cells. For tens of thousands of suffering patients, the therapy offers hope of living without debilitating pain.


But the Biden administration seems determined to prevent such breakthroughs from happening in the future.


Comentários

Não foi possível carregar comentários
Parece que houve um problema técnico. Tente reconectar ou atualizar a página.
bottom of page